New Tools and Strategies for Tuberculosis Diagnosis, Care, and Elimination
As the leading infectious cause of death worldwide, TB demands an urgent response that will realistically enable its elimination. Despite increases in funding for TB prevention and care in recent years, progress still lags behind targets for the WHO’s End TB strategy. Guest edited by Dr. Claudia Denkinger (FIND), Dr. Richard Chaisson, (Johns Hopkins), and Dr. Mark Hatherill (SATVI), this PLOS Medicine special issue focuses on new approaches to fighting and ending TB, including discovery and validation of novel biomarkers and diagnostic technologies, development of new treatments, testing of vaccines, and implementation studies of new strategies for diagnosis and treatment of TB.
Image Credit: GDJ, Pixabay and NIAID, Flickr
-
Richard Chaisson Dr. Richard Chaisson
-
Claudia Denkinger Dr. Claudia Denkinger
-
Mark Hatherill Dr. Mark Hatherill
-
PLOS Medicine Tuberculosis vaccines: Rising opportunities